Study will advance into expanded patient populations with myelodysplastic syndrome (MDS) and myelofibrosis (MF)SOUTH SAN FRANCISCO, Calif., April ...
Serial post-transplant chimerism assessment provided more reliable prognostic insight than a single early measurement.
Our columnist Andy Cochrane followed Des Linden at the six-day stage race across the Moroccan Sahara, aka "the toughest footrace on earth." ...
Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces that a ...
Approximately 2 million additional members in Maryland can now access care under the State entity of a major National insurer, extending Rocket ...
The National Board of Examinations in Medical Sciences (NBEMS) is set to close the application correction window for the ...
Published on April 01, 2026, in Volume 2, article number 19 of the journal Immunity & Inflammation , a collaborative team led by Prof. Cao at the ...
Myelodysplastic syndromes (MDS) are malignant disorders arising from hematopoietic stem cells, yet the precise epigenetic abnormalities occurring in the primitive stem cells remain poorly understood.
The National Board of Examinations in Medical Sciences has opened the NEET MDS 2026 application correction window, allowing ...
The National Board of Examinations in Medical Sciences (NBEMS) has opened the application correction window for NEET MDS 2026.
The Court set aside the Tribunals order as it relied on a precedent later reversed by the Supreme Court. The matter was remanded for fresh determination based on correct legal ...
New data highlight the activity and safety of MRD-guided preemptive azacitidine in patients with myelodysplastic neoplasms or ...